Ian Irwin

13.0k citations
86 papers · 10.2k · 3 hit papers · h-index 43

Impact in

  • Neurology top 0.05%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Neuroscience and Neuropharmacology Research
    • Nerve injury and regeneration
    • Neurotransmitter Receptor Influence on Behavior
    • Nuclear Receptors and Signaling
    • Genetic Neurodegenerative Diseases

Papers in

    • Parkinson's Disease Mechanisms and Treatments 51
    • Neurological disorders and treatments 14
    • Botulinum Toxin and Related Neurological Disorders 5
    • Neuroinflammation and Neurodegeneration Mechanisms 5
    • Neuroscience and Neuropharmacology Research 31
    • Neurotransmitter Receptor Influence on Behavior 16
    • Nerve injury and regeneration 7

Ian Irwin

85 papers receiving 10.0k citations

Hit Papers

Pargyline Prevents MPTP-Induced Parkinsonism in Primates 1984 · 492 citations
4920+14+28Years since publication10002.0k3.0k

Peers

Ian Irwin
Comparison fields: 5 of 129
  • Neurology 6.6k
  • Cellular and Molecular Neuroscience 5.9k
  • Neurology 1.3k
  • Toxicology 414
  • Developmental Neuroscience 382
Replace Richard E. Heikkila with:
Richard E. Heikkila United States
Donato A. Di Monte United States
Chuang C. Chiueh United States
J. William Langston United States
Teresa G. Hastings United States
Patricia K. Sonsalla United States
Jonathan M. Brotchie Canada
F. Javoy‐Agid France
Fabio Blandini Italy
James W. Tetrud United States
Ian Irwin relative to Richard E. Heikkila United States Richard E. Heikkila's profile →
Citations per field
00.5×
Richard E. Heikkila · 1×
Citations per year

Countries citing papers authored by Ian Irwin

Since Specialization
Citations

This map shows the geographic impact of Ian Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Irwin more than expected).

Fields of papers citing papers by Ian Irwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Irwin. The network helps show where Ian Irwin may publish in the future.

Co-authors

The 25 scholars most cited alongside Ian Irwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ian Irwin Line = papers co-authored together Ian Irwin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Hit paper breakdown →
19833646
2
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
Hit paper breakdown →
1984740
3
Pargyline Prevents MPTP-Induced Parkinsonism in Primates
Hit paper breakdown →
1984492
4 1984372
5 1986255
6 1992197
7
MPTP: current concepts and controversies.
1986196
8
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
1984194
9 1991192
10 1988184
11 1986164
12 1987158
13 1987156
14
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.
1993154
15 1986152
16 1985138
17 1990132
18 1993118
19 1994115
20 1992114

About Ian Irwin

Ian Irwin is a scholar working on Neurology, Cellular and Molecular Neuroscience, Physiology, Pediatrics, Perinatology and Child Health and Neurology, having authored 86 papers that have together received 10.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (51 papers), Neuroscience and Neuropharmacology Research (31 papers), Neurotransmitter Receptor Influence on Behavior (16 papers), Neurological disorders and treatments (14 papers), Alzheimer's disease research and treatments (8 papers), Nerve injury and regeneration (7 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). The work is most often cited by research in Neurology (6.6k citations), Cellular and Molecular Neuroscience (5.9k citations), Neurology (1.3k citations), Toxicology (414 citations) and Developmental Neuroscience (382 citations). Ian Irwin has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include J. William Langston, James W. Tetrud, Philip L. Ballard, J. William Langston, Lysia S. Forno, Louis E. DeLanney, L.E. DeLanney, Donato A. Di Monte, Charles S. Rebert and G.A. Ricaurte. Their work appears in journals such as Brain Research, Journal of Neurochemistry, European Journal of Pharmacology, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact